Lisdexamfetamine Dimesylate Capsules

Mallinckrodt, Lisdexamfetamine, ADHD, aNDA, Lisdexamfetamine Dimesylate Capsules, FDA approval

Mallinckrodt Launches New FDA-Approved ADHD Drug Lisdexamfetamine

Anika Sharma

Mallinckrodt, a global specialty pharmaceutical company, has made waves with an announcement that’s set to reshape the Attention-Deficit/Hyperactivity Disorder (ADHD) ...